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Previously, we showed that neonatal induced chronic partial unilateral
ureteral obstruction (PUUO) of the multipapillary pig kidney de-
creased glomerular filtration rate (GFR) of the obstructed kidney. We
hypothesized that ANG II and nitric oxide (NO) are important for the
changes in renal function and in the present study we examined the
effects of chronic AT1 receptor blockade using CV-11974 (0.12 mg/h
candesartan from age 23 to 30 days) on kidney function development
after PUUO was induced in 2-day-old piglets. Moreover, the effect of
superimposed acute NO inhibition using NG-nitro-L-arginine methyl
ester (L-NAME; 15 mg/kg) was examined to identify if this has
diagnostic potential. PUUO significantly increased GFR in the non-
obstructed contralateral kidney independent of candesartan. In cande-
sartan-treated piglets, the L-NAME-induced GFR reduction seen in
normal and nonobstructed kidneys was absent in the partial obstructed
kidneys. Urine output and fractional excretion of water were increased
from the partial obstructed kidneys. Consistent with this immunohis-
tochemical analyses showed a reduced aquaporin-2 labeling in the
collecting duct principal cells. Moreover, renal sodium handling was
compromised by PUUO evidenced by an increased fractional excre-
tion of sodium which was enhanced by candesartan treatment. In
conclusion, our findings suggest that the counterbalance between AT1
receptor-mediated vasoconstriction and NO-mediated vasodilatation
which maintain GFR in normal young porcine kidneys is changed by
neonatal induced chronic PUUO. This may have diagnostic potential
in children with suspected congenital obstruction. Our results also
demonstrate compromised tubular functions in response to chronic
PUUO despite preservation of glomerular function.
hydronephrosis; stereology; glomerular filtration rate; aquaporin 2
PRENATAL DIAGNOSED UNILATERAL hydronephrosis persisting
postnatal may be caused by partial obstruction at the uretero-
pelvic junction and hydronephrosis is found in 0.5% of
newborns potentially leading to obstructive nephropathy (36).
Major challenges exist in the clinical management of the infant
with congenital obstructive nephropathy. Renal function of the
hydronephrotic kidney is often preserved despite severe dila-
tation (13). Measuring kidney function may therefore not
disclose obstruction-induced impairment at the cellular and
molecular levels including the activation of vasoconstrictors
and cytokines that has been documented in animal models (6).
Thus, for infants with unilateral hydronephrosis, there is a need
to predict which patients are candidates for pyeloplasty and to
estimate the acceptable duration of observation before proceed-
ing to surgical intervention (13).
In recent studies, we demonstrated that neonatal induced
partial unilateral ureteral obstruction (PUUO) in piglets de-
creases glomerular filtration rate (GFR) and causes a signifi-
cant reduction in the number of nephrons (11, 12, 14). How-
ever, the regulation of these pathophysiological changes has
not been addressed in the neonatal pig model. Several studies
have demonstrated that ANG II plays important roles for the
hemodynamic and cellular changes induced by unilateral ure-
teral obstruction (2, 5, 6). Moreover, it has been demonstrated
that both ANG II and AT1 receptor expression are increased
during neonatal ureter obstruction in rats (31, 45). In the
developing pig kidney, the AT1 receptor-mediated glomerular
vasoconstriction by ANG II, which is an important component
of GFR regulation (1), is counteracted by nitric oxide (NO)
(39, 40). Thus ANG II is likely to play a significant role in the
hemodynamic response of the partially obstructed pig kidney
which potentially can be modulated by NO inhibition.
ANG II is also known to play important roles in the renal
regulation of sodium and water handling (33). Via the AT1
receptors ANG II mediates sodium reabsorption in the proxi-
mal and distal tubules and in the collecting ducts of mature rat
kidneys (4, 25, 34). Renal sodium reabsorption is compromised
in response to PUUO induced neonatally in rats (37). Thus it is
important to examine this in pigs and to elucidate whether it is
modulated by AT1 receptor blockade. Renal water reabsorp-
tion is tightly regulated by aquaporin water channels, espe-
cially via aquaporin-2 (AQP2) located in the collecting duct
principal cells (29). AQP2 is predominantly regulated by
vasopressin leading to translocation of AQP2 from the intra-
cellular compartment to the apical membrane (17). Recent
studies demonstrated reduced abundance of AQP2 which was
associated with impaired urinary concentrating ability in rats
with neonatally induced PUUO (37, 38). The role of the
renin-angiotensin system in the regulation of renal water han-
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dling in response to neonatally induced PUUO has not been
examined in pigs.
The cardiovascular and renal systems of pigs are more
similar to humans than are the systems in other species includ-
ing the rat (41). Furthermore, the porcine kidney has urine
transport characteristics and predominantly short looped
nephrons similar to the human kidney (10, 30, 41), factors
likely to be important when studying conditions of urinary flow
hindrance. The pig model of neonatal induced PUUO may
therefore more likely reflect changes in the human obstructed
kidney than the rodent kidney.
In this study, we therefore examined the effects of chronic
AT1 receptor blockade on single-kidney GFR and single-
kidney tubular sodium and water handling to identify whether
this intervention will provide markers of obstruction. PUUO
was induced during ongoing nephrogenesis in 2-day-old pig-
lets. After completion of nephrogenesis, which requires an
intact ANG II response (19, 20), the AT1 receptor was blocked
using candesartan. Hypothesizing that NO-mediated vasodila-
tor counterbalance is more pronounced during obstruction the
potential of using NO inhibition for diagnostic purpose in
children with suspected unilateral obstruction was subse-
quently addressed by comparing single-kidney GFR before and
after a bolus infusion of NG-nitro-L-arginine methyl ester
(L-NAME).
MATERIALS AND METHODS
Experimental design and pharmacological intervention. The exper-
iments were performed on 2-day-old female Danish Landrace pigs
weighing 1.8  0.4 kg who were randomized to four experimental
groups of which siblings were equally distributed. At age 23 days a
2-ml osmotic mini-pump (ALZET Osmotic Pump, DURECT, Cuper-
tino, CA) was implanted subcutaneously under light ketamine seda-
tion and subcutaneous lidocaine anesthesia in the groin of each piglet
releasing candesartan (kindly provided by Astra-Zeneca Sweden)
dissolved in physiological saline (groups shamcan and PUUOcan)
or saline only (groups sham and PUUO). All animals were transported
and housed under the same conditions. The study complied with the
Danish regulations for the care and use of experimental animals and
was approved by the Danish Animal Experiments Inspectorate.
Experimental groups. The Sham group involved (n  12) sham
operation of the left ureter at age 2 days. The Shamcan group
involved (n  10) sham operation of the left ureter at age 2 days and
candesartan treatment at a dose of 0.12 mg/h from day 23 to 30. The
PUUO group involved (n 11) partial obstruction of the left ureter at
age 2 days. The PUUOcan group involved (n  12) partial obstruc-
tion of the left ureter at age 2 days and candesartan treatment at a dose
of 0.12 mg/h from day 23 to 30.
During investigations at age 30 days, 15 mg/kg L-NAME (Sigma)
dissolved in physiological saline was given as an intravenous bolus.
Ambulatory blood pressure measurements (Veterinary Blood Pressure
Monitor, CAS Medical Systems) were performed once a day, three
times before (from age 15 to 22 days), and three times during
treatment with candesartan or saline (from age 23 to 30 days) and
mean values were calculated.
Induction of PUUO at 2 days of age. The operative procedure has
previously been described in detail (11, 44). In brief, under isoflurane
anesthesia a 3- to 3.5-cm flank incision was made on the left side
using sterile technique. The muscle layers were divided and the
peritoneum was gently pushed medially. The left ureter was identified
at the lower renal pole, and 3 cm were carefully mobilized, pre-
serving the periureteral adventitial tissue. A 2- to 2.5-cm longitudinal
slit was made in the adjacent psoas muscle. The piglet was then
randomized to one of the four experimental groups. The obstruction
was created using the method of Ulm and Miller (44) embedding the
mobilized ureter in the muscle slit and closing the muscle with three
5–0 nylon sutures. In the sham-operated groups, the ureter was
exposed but not obstructed.
Examinations at 30 days of age. The pigs were sedated with an
intramuscular injection of 5 mg/kg ketamine and 0.5 mg/kg midazo-
lam. An additional intravenous injection of 5 mg/kg ketamine was
given and orotracheal intubation was established (tube size 3.5 to 4).
The pigs remained anesthetized with an intravenous infusion of 0.3
mg kg1 min1 ketamine, 5 g kg1 min1 midazolam, and 2.5
g kg1 min1 pancuronium and were ventilated with a gas mixture
of O2 and N2O (1:2), tidal volume 1.8, 26 breaths per minute adjusted
according to pH. A standardized hydration regimen with intravenous
isotonic saline 12 ml kg1 h1 was continued throughout the exper-
iment.
Through bilateral flank incisions, the ureters were located retroper-
itoneal and cannulated with ureteral catheters (Ch 6) for urine collec-
tion including sampling for urine culture. Through a neck incision, the
right carotid artery and jugular vein were isolated and catheters were
inserted by use of a Seldinger technique; the venous catheter was used
for infusion of 51Cr-Ethylenediaminetetraacetic acid (51Cr-EDTA)
and L-NAME, the arterial catheter was used for continuous blood
pressure monitoring using a pressure transducer (Cardio Med) and for
blood sampling.
Renal function measurements. The day before clearance measure-
ments 75 mg lithium carbonate (Nycomed DAK) was given orally to
obtain measurable plasma lithium concentrations without affecting
kidney function. Single-kidney GFR was measured by a continuous
infusion clearance technique using 51Cr-EDTA (priming injection 5
MBq followed by a sustained infusion 8 MBq/h). After a 60-min
equilibration period, urine was collected from each kidney separately
and arterial blood samples were taken at 30-min intervals. Mean
arterial pressure and heart rate were measured continuously. Blood
samples were centrifuged and 200-l plasma samples were counted
together with plasma blanks and 200-l urine samples in a well
crystal scintillation detector (Cobra, Packard) to a statistical accuracy
of 1% and corrected for background activity and radioactive decay
during counting. Plasma and urine concentrations of lithium were
measured by atomic absorption (Perkin-Elmer atomic absorption
spectrophotometer 290B). Urine and plasma sodium concentrations
were measured in a continuous flow system (ABL 300 Radiometer).
The urine output volumes were measured by weighing the samples. At
the end of experiments, the kidneys were antegrade perfusion fixed via
the abdominal aorta using 4% phosphate-buffered formalin. Kidneys
were removed and the animals were euthanized under anesthesia
using potassium-chloride.
Immunohistochemistry. After removal, the kidneys were weighed,
cut in 4-mm-thick horizontal slices, and stored in 4% formalin. The
slices were numbered sequentially, dehydrated, and paraffin-embed-
ded. Random slices from the middle third of the kidneys were chosen
and cut in 2.5-m-thick sections using a calibrated microtome (Mi-
crom HM 355, Walldorf, Germany). Sections were single labeled with
AQP2 antibody (7661ap) diluted 1:3,000 in PBS with 0.1% BSA and
0.3% Triton X-100, incubated with horseradish peroxidase-conju-
gated second antibody (P448, goat anti-rabbit immunoglobulin,
DAKO), and visualized with 0.05% 3,3-diaminobenzidine tetrachlo-
ride (Kem-en Tek, Copenhagen, Denmark) for identification of the
primary antibody. Using a Leica DMRE light microscope, the sections
were examined in a blinded fashion describing the labeling intensity
of the collecting duct principal cells as homogenous or heterogeneous
and the presence of AQP2 labeling in the apical plasma membrane.
To examine the density of principal cells in the collecting ducts,
double labeling with AQP2 and [H]ATPase antibodies was per-
formed as follows. Sections were incubated with rat polyclonal AQP2
antibodies raised to chicken (cc256ap kindly provided by Dr. M.
Knepper, LKEM, National Heart, Lung, and Blood Institute, National
Institutes of Health, Bethesda, MD) diluted 1:10,000 on the first day
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of the procedure. After overnight incubation, this was followed by a
second incubation with peroxidase secondary antibodies (Abcam ab
6877–1) and visualized with 3,3-diaminobenzidine (DAB; Kem-En-
Tec). After blockade of remaining peroxidase, the sections were
incubated overnight with the primary rabbit [H]ATPase antibodies
raised polyclonal to the H7659 15 COOH-terminal peptide in rabbit
1:100 dilution followed by a second incubation with goat-anti-rabbit
P448 (DAKO, Glostrup, Denmark) and visualized by SK-4700 (Vec-
tor Laboratories). Sections from partial obstructed and sham-operated
kidneys were labeled at the same time with the same solutions to
allow for comparison.
Quantification of principal cells. To ensure that principal cells that
expressed even very low levels of AQP2 antibody were detected,
sections were double labeled with antibody against AQP2 and
[H]ATPase (intercalated cells in the collecting ducts) as described
above and nuclear staining was omitted. Cell counting was performed
using a microscope (Olympus BX-50) equipped with a motorized
object stage enabling movement from one field of view to another in
the x to y direction in a systematic uniformly random fashion (step
length 1,800 m). Images of the sections were viewed on a computer
screen using a 40 objective lens and a 3 CCD color video camera.
Stereological software (CAST, Visiopharm, Hillerød, Denmark) was
used to superimpose two point grids with 4 and 256 test points. The
cortex and medulla were separated using the arcuate arteries and the
presence of glomeruli and proximal tubules in the cortex. The anti-
body against [H]ATPase also stains the brush border and subvillar
invaginations of proximal tubules (22) which were not included in the
counting. The volume fraction of AQP2 or [H]ATPase-positive cells
in the cortex and medulla, respectively, was calculated as
Vv(structure,ref)	P(structure) /	P(total)
where Vv(structure,ref) is the volume fraction of the structure (e.g.,
AQP2-positive cells) in the reference space (e.g., cortex), P(structure) is
the number of points falling on the component, and P(total) the number
of points falling on the reference space (including the component).
The whole kidney volume densities were converted to absolute
quantities by multiplying the total kidney volume estimated by the
Cavalieri principle of a quarter of the kidney sampled using system-
atic uniformly random sampling (32). The sections were corrected for
paraffin-induced shrinkage. Small kidney samples were weighed and
the weight was converted to volume by multiplying with 1.04 cm3/g
(volume before). The volume of kidney samples after paraffin em-
bedding (volume after) was estimated by point counting and the
principle of Cavalieri (32). Tissue deformation was equal to 1 
(volume after/volume before) which was accounted for.
For all tissue preparation and stereological quantification, the
observer was naive to the origin of the histological sections.
Calculations and statistics. Clearance values (CX) were calculated
as the product of urinary solute concentration (UX) and urine output
(UO) divided by the plasma concentration (PX) over time as milliliters
per minute per kilogram of body weight. The fractional excretions
(FEX) were calculated as (CX/GFR)*100. The tubular handling of
sodium and water was investigated using the lithium clearance tech-
nique (42). The fractional excretion of lithium represents the frac-
tional delivery of sodium and water at the end of the proximal tubules.
Using the renal clearances of 51Cr-EDTA, sodium, and lithium, the
following parameters were calculated
GFR: C51Cr-EDTA U51Cr-EDTA UO/P51Cr-EDTA
FE of sodium: FENa (CNa /C51Cr-EDTA)100
FE of water: FEW (UO/C51Cr-EDTA)100
FE of water and sodium from the proximal tubules
PFEW-Na (CLi /C51Cr-EDTA)100
FE of water from the distal tubules: DFEW (UO/CLi)100
FE of sodium from the distal tubules: DFENa (CNa /CLi)100
Values are presented as mean and coefficient of variation (CV;
SD/mean) and compared using ANOVA and post hoc Student’s t-test
(unpaired for comparison between groups, paired for comparison
within individual pigs). In addition, comparison was done after log
transforming the data. Volume fractions and absolute AQP2 values
are compared using unpaired Student’s t-test. Values were considered
statistically significant at P 
 0.05.
RESULTS
All pigs had macroscopically normal appearing left kidneys
at study entry and right kidneys at study end.1 Urine culture at
30 days did not demonstrate urinary tract infection. Body
weight did not differ between groups (NS) and all partial
obstructed kidneys were found to have significant hydrone-
phrosis (grade three to four) at age 30 days. Mean arterial
pressure was measured ambulatory once a day three times
before (from age 15 to 22 days) and three times during
candesartan or saline treatment (from age 23 to 30 days) and
did not differ between groups (data not shown).
PUUO increased GFR in nonobstructed contralateral kid-
neys independent of AT1 receptor blockade. In the PUUO
groups, single-kidney GFR was reduced in the partial ob-
structed kidney compared with the contralateral nonobstructed
kidney independent of candesartan treatment (see Table 2).
Moreover, in the PUUO pigs single-kidney GFR increased
significantly in the nonobstructed contralateral kidneys com-
pared with sham-operated controls which was also independent
of candesartan treatment (see Table 2).
AT1 receptor blockade uncovered the single-kidney GFR
response to L-NAME after PUUO. To identify whether NO
inhibition may have a diagnostic potential in children with
congenital hydronephrosis, single-kidney GFR was measured
before and after a bolus infusion of L-NAME in the four
experimental groups (see Table 2). As a clinical useful ap-
proach, L-NAME was given intravenously, and this signifi-
cantly increased mean arterial pressure in all groups (Table 1).
Importantly, the increase was of identical magnitude in all four
groups. L-NAME did not change single-kidney GFR in the
kidneys of saline-treated, sham-operated and PUUO pigs com-
pared with the value before L-NAME was given. However, in
pigs pretreated with candesartan, L-NAME decreased single-
kidney GFR in the nonobstructed kidneys of the PUUO group
and in the kidneys of the sham-operated pigs. In contrast,
L-NAME did not change single-kidney GFR in the partially
obstructed kidneys of the candesartan-treated pigs (Fig. 1 and
Table 2).
1 The number of animals included varied between the renal function and
immunohistochemical analyses and the exact number of animals included for
each analysis is given in the tables and legends. Seven animals were lost due
to anesthesia-related death (n  3) or failure to thrive (n  4). Four animals
were excluded from the renal function studies because of loss of osmotic
pumps immediately before investigation (n  2), unstable urine production
(n  1), and urinary catheter occlusion (n  1). A further four animals had
renal function measured by a different procedure and are therefore excluded
from the function studies. In four animals, the plasma lithium concentrations
were inadequate for valid lithium clearance calculation. In four animals the
perfusion fixation failed.
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PUUO increased urine output and fractional water excre-
tion which is associated with reduced AQP2 labeling and
preserved number of principal cells. The measurements of
tubular function were done before the piglets were given
L-NAME. Partial obstruction significantly increased urine out-
put (UO) and fractional water excretion (FEW) compared with
sham-operated kidneys (Table 3). The increase was partly due
to an increase in DFEw, although this did not reach statistical
significance. The trend toward an increased DFEw raises the
possibility that AQP2 expression may be downregulated and
plays a role in the PUUO-induced increase in diuresis. We
therefore analyzed AQP2 abundance by semiquantitative scor-
ing of AQP2 staining intensity by systematic analysis of a cross
section containing both cortex and medulla from the middle
part of each left kidney. As UO and FEW did not differ between
candesartan- and saline-treated partial obstructed kidneys (Ta-
ble 3), only the saline-treated groups were studied. In the
partial obstructed kidneys, there was a consistent heteroge-
neous and reduced AQP2 distribution in the collecting duct
principal cells (Fig. 2A), whereas the distribution of AQP2 in
the sham-operated kidneys was clearly more homogenous (Fig.
2B). To study whether the compromised urinary concentrating
ability in the partial obstructed kidneys could be explained by
tubular cell destruction and thereby a reduced number of
principal cells, we quantitated the volume of AQP2-positive
cells by use of stereology. To ensure that even principal cells
with very low AQP2 staining were included, [H]ATPase
staining for intercalated cells were added and nuclear staining
was omitted (Fig. 3). The volume density of AQP2-positive
cells in the cortex and in the medulla did not differ between
partial obstructed or sham-operated kidneys (Table 4). Further-
more, the absolute volumes of principal cells in the whole
kidney did not differ between the two groups (Table 4).
PUUO increased sodium clearance and fractional sodium
excretion. PUUO significantly increased CNa and FENa com-
pared with sham-operated kidneys (Table 3). Candesartan did
not change CNa and FENa in the partial obstructed kidneys
(Table 3) but significantly increased DFENa compared with
controls suggesting an enhanced AT1 receptor involvement in
distal sodium reabsorption during neonatal PUUO.
DISCUSSION
The main results of the present study, using a well-estab-
lished neonatal pig model with high analogy to the human
kidney, demonstrated that chronic PUUO led to 1) a GFR
increase in the nonobstructed contralateral kidney independent
of AT1 receptor blockade, 2) a change in the GFR response to
intravenous NO inhibition during AT1 receptor blockade, 3)
increased water excretion associated with reduced AQP2 abun-
dance without a reduction in the volume of principal cells, and
4) increased tubular sodium excretion. AT1 receptor blockade
increased the fractional excretion of sodium from the distal
tubules in the partial obstructed kidneys demonstrating that
ANG II plays a role in distal sodium reabsorption during
neonatal PUUO.
GFR increase in nonobstructed kidneys is not AT1 receptor
mediated. In PUUO pigs, GFR increased in the nonobstructed
contralateral kidney. Previously, we demonstrated in this pig
model with PUUO that contralateral nonobstructed kidney
GFR does not increase uniformly despite a significant GFR
reduction of the partial obstructed kidney (14). Thus, consistent
with observations in neonatal rat models, changes in contralat-
eral nonobstructed GFR are not an unambiguous finding (23,
24), suggesting that an increase in contralateral kidney GFR is
not only caused by stimuli present when there is significant
decrease in GFR of the partial obstructed kidney.
AT1 receptor blockade did not prevent the GFR increase in
the contralateral kidney in PUUO pigs, suggesting that coun-
terregulatory vasoactive mediators are activated. This is con-
sistent with findings in the unilateral obstructed neonatal
guinea pig where contralateral kidney vascular resistance was
unaffected by ANG I-converting enzyme inhibition (7). Alter-
natively, sympathetic nerve activity may play a role in the
contralateral kidney adaptive vasoactive response as indicated
in the neonatal rat model of unilateral occlusion (9).
AT1 receptor blockade uncovered the single-kidney GFR
response to L-NAME after PUUO. The balance between ANG
II-mediated vasoconstriction and NO-mediated vasodilatation
normally influences GFR. We studied the GFR response to
systemic NO inhibition during neonatal PUUO where the ANG
Table 1. Body weight, MAP, and plasma sodium in the four experimental groups
Sham (n  9) ShamCan (n  7) PUUO (n  7) PUUOCan (n  7)
Body weight, kg 4.86 (0.21) 4.84 (0.14) 4.86 (0.35) 4.66 (0.27)
MAP, mmHg 72 (0.13) 60 (0.13)* 69 (0.11) 63 (0.11)
MAP after L-NAME 102 (0.09)† 83 (0.13)† 102 (0.12)† 89 (0.15)†
PNa, mmol/l 135 (0.02) 134 (0.03) 134 (0.02) 135 (0.02)
Values are mean (CV). *P 
 0.05 candesartan (can) vs. saline. †P 
 0.01 before L-NAME vs. after L-NAME. MAP, mean arterial pressure; PNa, plasma
sodium; PUUO, partial unilateral ureteral obstruction.
Fig. 1. Single-kidney glomerular filtration rate (GFR; ml  min1  kg body
wt1) in candesartan-treated piglets before (pre) and after (post) a bolus
infusion of NG-nitro-L-arginine methyl ester (L-NAME). L-NAME significantly
decreased GFR in the nonobstructed kidneys of partial unilateral ureteral
obstruction (PUUO) piglets (nonobs) and in the intact kidneys of sham-
operated piglets (control). In contrast, L-NAME did not change GFR in the
partially obstructed kidneys (obs) of the PUUO animals.
F924 ANG II AND RENAL FUNCTIONAL CHANGES IN NEONATAL PUUO
AJP-Renal Physiol • VOL 292 • MARCH 2007 • www.ajprenal.org
 by 10.220.33.2 on January 9, 2017
http://ajprenal.physiology.org/
D
ow
nloaded from
 
II system is enhanced, to identify whether this approach may
be clinically useful. Thereby the potential of using the vaso-
active counterbalance between ANG II and NO for diagnostic
purpose in suspected neonatal obstruction could be explored.
Because of the intravenous administration route, L-NAME
increased systemic blood pressure. This may explain the un-
changed GFR levels in control pigs as opposed to the findings
by Solhaug and colleagues (40) where intrarenal L-NAME
administered directly via the renal artery reduced GFR by 30%
in the normal piglet. However, this approach is not clinically
feasible. The absence of GFR changes despite systemic blood
pressure increase in the present study may be due to activation
of renal autoregulation modulating afferent arteriolar tone by a
combination of tubuloglomerular feedback and myogenic ef-
fects (27). The complex autoregulatory mechanisms may to
some extent be influenced by ANG II and NO as suggested in
the studies from the normal adult rat kidney (18). Importantly,
the piglets in the present study were studied under strictly
standardized conditions and the L-NAME-induced moderate
blood pressure increase did not differ between experimental
groups.
During AT1 receptor blockade, NO inhibition decreased
single-kidney GFR in control kidneys. Likewise, NO inhibition
decreased single-kidney GFR in the nonobstructed kidney but
not in the partially obstructed kidney of the candesartan-treated
PUUO groups. GFR regulation is complex and involves inter-
action between a variety of hormone systems and neural
factors. This interaction is modulated by the ureter obstruction
making interpretation of GFR changes induced by pharmaco-
logical manipulation during obstruction even more complex. In
addition to ANG II, previous studies in adult obstructive rat
models have shown increased expression of the vasoconstrictor
endothelin (21). Furthermore, ANG II synthesis inhibition by
enalapril demonstrated an increased expression of endothelin
receptors in adult mice with ureter obstruction (28). Vasocon-
striction maintained by endothelin even in the presence of
ANG II blockade is compatible with the observations in the
present study suggesting that GFR is regulated by other medi-
ators during partial ureter obstruction. It may be speculated that
the vasoconstrictor thromboxane A2 (TxA2) or the vasodilator
prostaglandins also are involved in GFR regulation in response
to PUUO. However, previous studies of chronic neonatal
PUUO in guinea pigs (8) and of chronic UUO in pigs (16) did
not demonstrate changes in renal function after TxA2 block-
ade, whereas TxA2 blockade improved the postobstructive
function in rats (35), suggesting both species- and design-
dependent differences in the response to TxA2 blockade.
The present observation that administration of L-NAME-
induced changes in the single-kidney GFR response during
AT1 receptor blockade in piglets with PUUO indicates that
simultaneous blockade of ANG II and NO may have a potential
to identify infants who are candidates for pyeloplasty among
infants with unilateral hydronephrosis. Furthermore, our data
may suggest that the individual GFR changes after NO inhi-
bition could be related to the level of functional deterioration in
the obstructed kidneys. This aspect needs to be further ad-
dressed in animal models together with the challenge to esti-
mate the acceptable duration of observation before proceeding
to surgical intervention. A characteristic of the multipapillary
kidney model is the variation in the GFR response to a standard
obstruction procedure. This is in agreement with the variation
in renal function observed in children with hydronephrosis
(13), suggesting that the pig model is valuable when results are
compared with the clinical situation. However, this variation
may also make statistical comparisons difficult in clinical
studies.
PUUO is associated with reduced AQP2 abundance and
impaired tubular water reabsorption. In the present study, we
demonstrated that water excretion was significantly increased
Table 2. GFR before and after L-NAME in the four experimental groups
Sham (n  9) ShamCan (n  7) PUUO (n  7) PUUOCan (n  7)
Left kidney Right kidney Left kidney Right kidney Obstructed Nonobs. Obstructed Nonobs.
GFR pre mlmin1kg body wt1 1.53 (0.16) 1.49 (0.26) 1.71 (0.16) 1.74 (0.15) 1.35 (0.45) 1.94 (0.17)ab 1.20 (0.73) 1.96 (0.22),b
GFR post mlmin1kg body wt1 1.47 (0.23) 1.45 (0.27) 1.50 (0.23),c 1.45 (0.21)c 1.69 (0.35) 1.87 (0.26) 1.10 (0.75) 1.61 (0.36)c
Values are mean (CV). aP 
 0.05 PUUO vs. sham. bP 
 0.05 obstructed vs. nonobstructed (nonobs.). ,bP  0.067. cP 
 0.01 before L-NAME vs. after
L-NAME ( ,cP 
 0.08). GFR, glomerular filtration rate; pre, before; post, after.
Table 3. UO and renal clearance data in the four experimental groups
Sham (n  9§) ShamCan (n  7) PUUO (n  7§) PUUOCan (n  7§)
Left kidney Right kidney Left kidney Right kidney Obstructed Nonobs. Obstructed Nonobs.
UO, lmin1kg body wt1 14.3 (0.55) 13.6 (0.47) 24.5 (0.52)† 23.4 (0.40)† 34.6 (0.39)*‡ 20.1 (0.49) 38.8 (0.30)* 29.4 (0.41)
FEW, % 0.95 (0.50) 0.97 (0.45) 1.47 (0.58) 1.43 (0.54) 4.49 (1.33)*‡ 1.04 (0.47) 11.97 (1.35)* 1.57 (0.45)
CNa, lmin1 kg body wt1 5.3 (1.05) 5.4 (0.89) 10.1 (0.78) 9.5 (0.79) 14.7 (0.75)* 9.2 (1.20) 24.2 (0.43)* 19.6 (0.97)
FENa, % 0.33 (0.93) 0.35 (0.78) 0.62 (0.87) 0.57 (0.82) 1.22 (0.52)*‡ 0.49 (1.21) 5.78 (1.45)* 1.09 (1.00)
PFEW-Na, % 26 (0.56) 25 (0.42) 35 (0.54) 34 (0.52) 44 (0.56) 31 (0.35) 68 (0.66) 38 (0.51)
DFEW, % 6.0 (0.89) 4.9 (0.69) 4.7 (0.38) 4.8 (0.45) 8.8 (0.88) 4.3 (0.68) 9.1 (1.10) 4.5 (0.50)
DFENa, % 1.6 (0.72) 1.5 (0.70) 1.7 (0.63) 1.7 (0.61) 2.6 (0.67) 2.2 (1.30) 5.7 (0.96)* 3.1 (1.04)
Values are measured before the administration of L-NAME and given as mean (CV). *P 
 0.05 PUUO vs. sham. †P 
 0.05 can vs. saline. ‡P 
 0.05
obstructed vs. nonobstructed. UO, urine output; FEW, fractional excretion of water; CNa, sodium clearance; FENa, fractional excretion of sodium; PFEW and
PFENa, proximal fractional excretion of water and sodium, respectively; DFEW and DFENa, distal fractional excretion of water and sodium, respectively.
§N  7, n  5, and n  6 for PFEW and PFENa in sham, PUUO, and PUUOcan groups, respectively; n  7 for CNa in sham group.
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from the PUUO kidneys. The water excretion from the prox-
imal and the distal tubules, respectively, was quantitated using
the lithium clearance technique. This technique has been
widely used and is generally accepted as being the best indirect
method available for estimating the delivery of sodium and
water from the proximal tubules to the loop of Henle (42).
Although a great number of experimental studies have tested
the lithium clearance method against micropuncture measure-
ments (42), this is not possible in the pig model.
Our results indicate that distal tubule water excretion was
increased, although this did not reach statistical significance.
To further address the mechanisms involved in the compro-
Fig. 2. Immunohistochemical staining with
primary antibodies that recognize AQP2
(brown) in collecting duct cells. Heteroge-
neous AQP2 labeling intensity (arrows) in
partial obstructed (A) and homogeneous
AQP2 labeling intensity (arrows) in sham-
operated kidneys (B).
Fig. 3. Double labeling of sections from sa-
line-treated piglets. Labeling was performed
with primary antibodies that recognize AQP2
(brown) and [H]ATPase (blue). The AQP2
staining intensity was reduced in the medul-
lary [A and C (high magnification of inset in
A)] and cortical (E) collecting ducts of partial
obstructed kidneys compared with the stain-
ing intensity of medullary (B and D) and
cortical (F) collecting ducts in sham-operated
kidneys.
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mised tubular water reabsorption, AQP2 abundance was sys-
tematically examined using specific immunostaining tech-
niques. Analyses of the kidney sections were done semiquan-
titatively by viewing the entire section in a blinded fashion.
This demonstrated that AQP2 expression was reduced in the
partial obstructed kidneys. Recent studies in the neonatal
obstructed rat model documented reduced AQP2 expression
which was associated with decreased solute-free water reab-
sorption demonstrating a relationship between molecular and
functional changes in the obstructed kidney (37, 43). Our study
is the first to show a similar functional association between the
AQP2 expression and the ability to reabsorb water in the
multipapillary kidney.
In the partial obstructed kidneys, there were heterogeneous
AQP2 labeling and distribution as opposed to the homogenous
distribution found in the control kidneys. Our findings are
consistent with the first original observation demonstrating that
urinary tract obstruction is associated with downregulation of
AQP2, which is more severe in some parts of the collecting
ducts than others (15). It could therefore be speculated that
local ANG II generation in the obstructed kidney, which has
been shown to interact with AQP2 regulation in rat kidneys
subjected to neonatal PUUO (43), is heterogeneously affected
by the obstruction.
Candesartan treatment did not change the water excretion
parameters compared with saline in the partial obstructed
kidneys. Therefore, the AQP2 analyses were restricted to the
latter. However, in a recent study in rats candesartan treatment
prevented the obstruction-induced reduction in solute-free wa-
ter reabsorption after 10 wk of severe partial obstruction (43).
Consistent with the improved water reabsorption capacity,
candesartan treatment was also associated with prevention of
PUUO-induced dysregulation of AQP2 suggesting that cande-
sartan prevented the obstruction-induced effects localized to
the distal tubules. The results from the present study demon-
strate that the fractional proximal water excretion tended to
increase after candesartan treatment in the partial obstructed
kidneys. In the present study, pigs were examined after 30 days
of mild obstruction, whereas the effects of AT1 receptor
blockade were studied after 10 wk of severe obstruction in the
rat model. Thus it is possible that the response to AT1 receptor
blockade in the obstructed pig kidney may change with time to
a response more similar to the rat study.
To address whether the compromised ability to reabsorb
water was due to tubular destruction and thereby a decrease in
the volume of principal cells, we quantitated these by use of
stereological technique. The results demonstrated that the vol-
ume of principal cells was not reduced indicating that the
compromised water reabsorption was not due to a decreased
number of principal cells but rather to a reduction in AQP2
protein abundance. In theory, this could indicate reversibility
of the compromised water reabsorption supporting the view
that normalization of AQP2 levels takes place several weeks
after release of bilateral occlusion in rats (26).
AT1 receptor blockade increased distal fractional sodium
excretion from the partial obstructed kidney. PUUO signifi-
cantly increased sodium excretion consistent with observations
in obstructed rat kidneys (37). Although AT1 receptor block-
ade did not change overall sodium excretion, it increased distal
tubule fractional sodium excretion, indicating that ANG II may
play a role in distal tubule sodium reabsorption during neonatal
PUUO in this model. This finding is in contrast to the de-
creased sodium excretion observed from obstructed weanling
rat kidneys in response to enalapril treatment (3). Moreover,
the suggested potential renoprotective effect of ANG II inhi-
bition in the weanling rat may not be present in the neonatal
obstructed multipapillary pig kidney. This would limit the
therapeutic potential of blocking the renin-angiotensin system
postnatal to prevent renal tubular damage in children.
The increased distal tubule sodium output from partial ob-
structed kidneys during AT1 receptor blockade demonstrates
an upregulation of ANG II-mediated sodium reabsorption in
this segment during neonatal PUUO. In vitro studies have
shown that renal epithelial sodium channels, mediating sodium
reabsorption in collecting duct cells, are activated by AT1
receptors (34). It may therefore be speculated that PUUO
induced during renal maturation led to an upregulation of distal
tubule epithelial sodium channel subunits to compensate for
the increased sodium load presented from the proximal tubules.
This aspect may be important in predicting tubular damage
during congenital hydronephrosis and needs to be addressed in
more detail in a future study.
In conclusion, our findings in this study using a multipapil-
lary kidney model with high analogy to human congenital
urinary tract obstruction demonstrate that the changes in kid-
ney function are not solely ANG II dependent and suggest that
the counterbalance between AT1 receptor-mediated vasocon-
striction and NO-mediated vasodilatation which maintain GFR
in normal young porcine kidneys is changed by neonatal
induced chronic PUUO, possibly by the activation of other
vasoactive mediators. The impact of ANG II and the NO
system on single-kidney GFR may offer possibilities to detect
significant obstruction in children with urinary tract dilatation
and suspected obstruction. Moreover, the study demonstrates
that tubular functions are likely to be compromised despite
preservation of GFR during neonatal induced PUUO. The
decreased AQP2 abundance associated with increased water
excretion in response to partial ureter obstruction indicates that
downregulation of AQP2 protein abundance may play a role in
renal function in neonatal PUUO in the multipapillary kidney.
As opposed to the intact neonatal kidney, ANG II mediates
distal tubule sodium reabsorption during chronic PUUO.
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Table 4. Volume fractions (medulla and cortex) and whole
kidney absolute volumes of AQP2-positive cells in partial
obstructed and sham-operated kidneys
from saline-treated piglets
Sham (n  8) PUUO (n  7)
Vv(AQP2,cortex) 12.6  103 (0.32) 13.8  103 (0.68)
Vv(AQP2,medulla) 33.0  103 (0.59) 30.3  103 (0.50)
AQP2-positive cell
volume, mm3 507  103 (0.60) 631  103 (0.50)
Values are mean (CV). Vv(AQP2,cortex), volume fraction of AQP2-positive
cells in the cortex; Vv(AQP2,medulla), volume fraction of AQP2-positive cells in
the medulla.
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